Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this session, "An Eagle's View - Evidence-based discussion on Iron Deficiency Anemia." This discussion will provide a high-level, evidence-based overview of Iron Deficiency Anemia (IDA), the most common nutritional deficiency worldwide. Despite its prevalence, IDA is often underdiagnosed and undertreated, leading to significant health consequences. This session will offer a fresh perspective on the latest clinical data, moving beyond traditional approaches to focus on effective and patient-centered management strategies.
The discussion will explore the evidence supporting different therapeutic options, including oral iron supplementation and intravenous iron infusions. We'll delve into the specific patient populations that benefit most from each approach, such as those with intolerance to oral supplements, pregnant women, or patients with chronic conditions. Recent research has highlighted the improved safety and efficacy of modern intravenous iron formulations, making them a more viable and often preferred option for rapid iron replenishment and symptom relief. We will also address the challenges in diagnosis, particularly when inflammatory markers are elevated.
Therefore, get an overall knowledge of the evidence-based best practices in the diagnosis and treatment of iron deficiency anemia. Listen to the webinar, absorb the shared knowledge, and follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
Infection Burden High With Myeloma T-Cell Therapies
3.
Study opens up possibility of bespoke prostate cancer treatment
4.
There is a 40% reduction in the risk of 9 cancers with good cardiorespiratory fitness.
5.
How Much of a Cancer Drug Is Too Much?
1.
Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma
2.
TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances
3.
Interpreting Iron Studies: What Your Blood Results Really Mean
4.
Immune Ecosystem Remodeling Within Solid Tumor Niches
5.
The Benefits and Risks of Thrombolytics: A Comprehensive Guide
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XV
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
From Guidelines to Practice: Hematology
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation